lncTAC
Latest round
- Series A
Last raised
- Jun 2026
Total raised
- Undisclosed
Investors
- 6
About lncTAC
, Ltd, trading as lncTAC, is a biotech company that focuses on research and development of lncRNA (long non-coding RNA) drugs. The founder and chairman of this company, Prof. Xu Song, is a PhD from the Peking Union Medical College of China and a postdoctoral fellow at Yale University. Mr. Lihua Ding, Co-founder and CEO, has 30 years of experience in the pharmaceutical industry. The company develops its own biotechnology, including lncTAC® and UNAST® technologies. UNAST® technology is a nucleic acid drug stabilization platform, while lncTAC® technology is an extrahepatic targeted delivery platform. The company generates revenue by providing lncRNA-based nucleic acid drugs. The company will focus on accelerating the critical process of lncRNA from validation to realization.
Who invested in lncTAC
6 investors across 2 rounds
See all investors in lncTAC
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about lncTAC
Who invested in lncTAC?
lncTAC has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has lncTAC raised?
lncTAC has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did lncTAC last raise money?
lncTAC's most recent round on record is a Series A, in Jun 2026.
What does lncTAC do?
, Ltd, trading as lncTAC, is a biotech company that focuses on research and development of lncRNA (long non-coding RNA) drugs.
Where is lncTAC headquartered?
lncTAC is headquartered in Chengdu, China.
Which VCs invest in companies like lncTAC?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at lncTAC's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like lncTAC? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.